What does GLP stand for?

GLP stands for glucagon-like peptide. It is a type of hormone your body produces naturally, mostly in your gut, right after you eat. The name might sound complicated, but it actually tells you exactly what this hormone is: a peptide (a short chain of amino acids) that looks structurally similar to glucagon (another hormone made in your pancreas).

There are two forms. GLP-1 and GLP-2. They come from same gene but do very different jobs. GLP-1 is one you hear about in news because it is basis for medications like Ozempic, Wegovy, Mounjaro, and Trulicity. GLP-2 works mainly on your intestinal lining and is not involved in blood sugar or weight management.

This article focuses on GLP 1, the form that matters for diabetes and obesity treatment.

Why is it called "glucagon like"?

Because GLP 1 is encoded inside same gene as glucagon. In early 1980s, scientists sequencing proglucagon gene discovered something unexpected. The gene did not just produce glucagon. It actually contained instructions for three separate hormones: glucagon, GLP-1, and GLP 2.

The new peptides looked structurally similar to glucagon under a microscope. So researchers named them "glucagon-like." But here is twist: even though GLP-1 and glucagon come from same gene, they do opposite things. Glucagon raises your blood sugar by telling your liver to release stored glucose. GLP-1 helps lower it by triggering insulin release from your pancreas.

Same gene. Opposite jobs. That is one of those details that surprises a lot of people.

What does GLP 1 actually do in your body?

Your gut releases GLP-1 within minutes of eating. It comes from specialized cells called L-cells in your small intestine and colon. Once in your bloodstream, it gets to work on several things at once.

It signals your pancreas to produce more insulin, but only when your blood sugar is elevated. That glucose-dependent action is what makes GLP-1 different from older diabetes drugs that could push blood sugar dangerously low.

It tells your pancreas to quiet down glucagon production. Less glucagon means your liver releases less stored sugar into your blood.

It slows gastric emptying. Food stays in your stomach longer, so sugar enters your bloodstream more gradually after meals. This also contributes to feeling full for a longer stretch after eating.

And it acts on hypothalamus in your brain. That is your appetite control center. GLP-1 sends a direct neurological signal that reduces hunger. This is not just "fullness from a slow stomach." It is your brain receiving a chemical message that you have had enough.

All of this happens naturally, every time you eat. The problem is it only lasts about two minutes before an enzyme called DPP-4 breaks GLP-1 down into inactive fragments. For a healthy person, that brief window is enough. For someone with type 2 diabetes, it is not.

How is GLP-1 connected to medications like Ozempic and Mounjaro?

GLP-1 medications are lab-built versions of this natural hormone. Scientists modified its structure so DPP-4 cannot destroy it as quickly. Instead of lasting two minutes, the drug version stays active for hours or days.

The drugs attach to same GLP-1 receptor your natural hormone uses. But they hold on much longer and produce a stronger, sustained effect. More insulin when needed. Less glucagon. Slower digestion. Reduced appetite. All of it stretched out over a clinically useful period.

Different drugs approach this in slightly different ways.

Semaglutide (the active ingredient in Ozempic and Wegovy) is built on human GLP-1 backbone and modified to resist DPP-4. It is given as a weekly injection, or as a daily pill in case of Rybelsus.

Dulaglutide (Trulicity) is also a human GLP-1 based drug, given weekly.

Tirzepatide (Mounjaro and Zepbound) is different. It activates both the GLP-1 receptor and a second receptor called GIP. That dual action is why it has shown stronger results for blood sugar and weight loss in clinical trials.

Exenatide (Byetta, Bydureon) was first GLP-1 drug, approved in 2005. It is built on exendin-4, a peptide found in Gila monster saliva that naturally resists DPP-4 breakdown.

And metformin, which people sometimes confuse with GLP-1 drugs, is a completely different class of medication. It works on your liver and muscle tissue. It does not activate GLP-1 receptor at all.

Is GLP-1 the same thing as a peptide?

GLP-1 is a peptide, yes. A peptide is just a short chain of amino acids, typically fewer than 50 linked together. GLP-1 is made of 30 or 31 amino acids depending on form. So every GLP-1 drug is technically a peptide drug.

But not every peptide is a GLP-1 drug. Collagen peptides, copper peptides, BPC-157, and muscle-building peptides are all peptides too. They share same basic structure (short amino acid chains) but work through completely different pathways in your body. A collagen supplement and semaglutide have nothing in common pharmacologically.

If someone tells you a peptide supplement "works like Ozempic," that is not accurate. The GLP-1 receptor agonist class is a specific, FDA approved category of drugs. Over the counter peptide products do not belong to it.

Conclusion

GLP stands for glucagon like peptide. It is a hormone your gut makes after eating. It lowers blood sugar, slows digestion, and reduces appetite. Your body breaks it down in about two minutes, which is fine for most people but not enough for someone managing diabetes or obesity.

GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Trulicity are engineered versions of this hormone that last much longer in your body. They are prescribed for type 2 diabetes and weight management, and research is exploring their potential for heart disease, liver disease, and neurological conditions.

If you are curious about whether a GLP 1 medication could be right for you, your doctor can walk you through the options based on your HbA1c, weight history, and full health picture.